Brief: Oasmia Pharmaceutical Signs License Agreement With Farmamondo Group

Vivesto AB

17/09/2021 06:19

Sept 17 (Reuters) - Oasmia Pharmaceutical AB  OASM.ST :
    * HAS SIGNED A LICENSE AGREEMENT WITH SWISS-BASED FARMAMONDO
GROUP
FOR COMMERCIALIZATION OF PACLICAL® (APEALEA®) IN RUSSIA AND
COMMONWEALTH OF INDEPENDENT STATES.
    * SIGNING OF THIS AGREEMENT HERALDS COMPLETION OF
OUT-LICENSING OF
APEALEA GLOBALLY AND OASMIA ANTICIPATES STARTING TO RECEIVE
ROYALTIES FROM THESE PARTNERSHIPS DURING 2022.

Source text for Eikon:  ID:nNDL6fQNLZ 
Further company coverage:  OASM.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))